Kings Path Partners LLC Purchases 17,550 Shares of The Pennant Group, Inc. $PNTG

Kings Path Partners LLC purchased a new stake in The Pennant Group, Inc. (NASDAQ:PNTG) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 17,550 shares of the company’s stock, valued at approximately $684,000. Kings Path Partners LLC owned about 0.05% of The Pennant Group as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PNTG. BlackRock Inc. bought a new stake in The Pennant Group during the 2nd quarter worth about $109,340,000. Wasatch Advisors LP boosted its stake in shares of The Pennant Group by 31.8% in the 2nd quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company’s stock valued at $69,103,000 after purchasing an additional 451,491 shares during the last quarter. Turtle Creek Asset Management Inc. boosted its stake in shares of The Pennant Group by 12,075.6% in the 1st quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company’s stock valued at $48,244,000 after purchasing an additional 1,569,823 shares during the last quarter. Paradigm Capital Management Inc. NY bought a new position in shares of The Pennant Group in the 2nd quarter valued at about $51,833,000. Finally, Dimensional Fund Advisors LP grew its position in shares of The Pennant Group by 1.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company’s stock worth $24,861,000 after buying an additional 11,943 shares during the period. 85.88% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on PNTG shares. Weiss Ratings raised shares of The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Royal Bank Of Canada increased their price objective on shares of The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a report on Thursday, August 20th. Truist Financial raised their price objective on shares of The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Wells Fargo & Company lifted their target price on shares of The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Six research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $42.00.

The Pennant Group Stock Down 1.1%

Shares of NASDAQ PNTG opened at $41.04 on Thursday. The stock has a market cap of $1.43 billion, a P/E ratio of 37.71, a P/E/G ratio of 2.70 and a beta of 1.25. The firm has a 50 day moving average price of $39.52 and a 200 day moving average price of $36.73. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.20 and a current ratio of 1.20. The Pennant Group, Inc. has a 52-week low of $22.25 and a 52-week high of $42.74.

The Pennant Group (NASDAQ:PNTG) last issued its earnings results on Wednesday, August 5th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.33 by $0.03. The firm had revenue of $297.98 million during the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. Analysts expect that The Pennant Group, Inc. will post 1.18 EPS for the current year.

The Pennant Group Company Profile

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.